Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy
Portfolio Pulse from Vandana Singh
U.S. District Judge Denise Cote ruled that expert witnesses cannot testify that Kenvue Inc's Tylenol could cause autism if taken during pregnancy, halting mass tort litigation involving around 500 lawsuits. The ruling found the methodologies of the plaintiffs' experts unsound. The litigation also involved Johnson & Johnson, CVS Health Corp, Walgreens Boots Alliance Inc, and Walmart Inc, who faced allegations over generic versions of Tylenol. Health experts still recommend acetaminophen, Tylenol's active ingredient, for pregnant individuals over aspirin or ibuprofen. Kenvue shares dropped 0.98% to $21.26.
December 20, 2023 | 3:51 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Kenvue's stock declined slightly after a judge ruled against allowing testimony that Tylenol causes autism, but the halt in litigation could be positive.
While Kenvue's stock experienced a small drop, the cessation of litigation may be viewed positively by investors in the short term, stabilizing the stock.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
CVS Health Corp, facing allegations over generic Tylenol, may see reduced legal risk after the ruling, potentially impacting its stock positively.
The ruling could decrease the legal exposure for CVS regarding the generic Tylenol, which might be seen as a positive development by investors.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Johnson & Johnson, the parent company of Kenvue, is indirectly affected by the ruling favoring Kenvue in the Tylenol litigation.
The favorable ruling for Kenvue likely reduces legal risks for Johnson & Johnson, potentially improving investor sentiment and reducing contingent liabilities.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Walgreens Boots Alliance Inc could benefit from the ruling against expert testimony on Tylenol, potentially easing legal concerns and benefiting its stock.
The dismissal of expert testimony in the Tylenol case may reduce the legal burden on Walgreens, which could be perceived positively by the market.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Walmart Inc's legal risks over generic Tylenol may decrease following the ruling, which could have a favorable impact on its stock in the short term.
The court's decision could mitigate Walmart's legal challenges related to Tylenol, potentially leading to a positive reaction in its stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50